FDA Investigator Kerun Hardeo

Kerun Hardeo has conducted inspections on 31 sites in 2 countries as of 10 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
31
Last Inspection Date:
10 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
100002964
Countries of Inspections:
United States of America, Canada
FDA Investigators that have inspected at least one site in common with Kerun Hardeo:
Alice S Tsao, Amy Wyan Mai, Andrew B Paglia, DPM, Benton M Ketron, Bernardica T Sculac Stern, Brandy D Brown, Byungja E Marciante, Charisse K Green, Cheryl A Grandinetti, Daniel Green, David M Mcnew, Demitria J Argiropoulos, Demitria J Xiradakis, Dr. Abhijit Raha, PhD, Dr. Mark J Seaton, PhD, Dr. Sriram Subramaniam, PhD, Evelyn Taha, Felix Maldonado, Gabriel Davila, Gary T Greco, George C Amedro, Gifford Whitehurst, Jr, Helen B Ricalde, Iram R Hassan, PhD, Irina Gaberman, Jacqueline S Warner, Jana J Lau, Joanne M Schlossin, Jogy George, Jonathan D Green, Joy P Matthias, Kara A Scheibner, PhD, Karen L Kosar, Kellie Leveille, Lata C Mathew, PhD, LCDR Chad N Thompson, Leena Thomas, Lisa Mathew, Lucilla Facchin, Margaret E Sarles, Matthew A Spataro, Melkamu Getie Kebtie, PhD, Michael F Skelly, PhD, Michael G Sinkevich, Michael R Dominick, Michael Serrano, Mohsen Rajabi Abhari, FDA, Nicholas C Mendiola, Nigel L Hirth, Omadevi Somai, Investigator, Paul Mouris, Russ E Davis, Sabine Francke, Satheesh Thomas, Seongeun Cho (Julia), PhD, Sheri L Stephenson, Simone E Pitts, Sripal R Mada, PhD, Tara K Carmody, Thomas P Hansen, Uduak M Inokon, Valerie Jgrecek Trinh, Wai H Lam, Xiaohan Cai, PhD, Yiying E Chen, Yiyue Zhang (nmi), PhD, Yuyan Liang

Kerun Hardeo's Documents

Publish Date Document Type Title
December, 2023 FDA 483 J. John Mann, M.D. - Form 483, 2023-12-05
December, 2022 FDA 483 Jack Michael Mann, M.D. - Form 483, 2022-12-06
September, 2022 FDA 483 Memorial Sloan Kettering Cancer Center - Form 483, 2022-09-20
August, 2022 FDA 483 Columbia University Medical Center IRB - Form 483, 2022-08-31
May, 2022 FDA 483 NYC Health + Hospitals/Bellevue - Form 483, 2022-05-06

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more